Digital Library
Close Browse articles from a journal
 
Search for with title:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             50 results found
no title author magazine year volume issue page(s) type
1 Activation of PPAR-δ in isolated rat skeletal muscle switches fuel preference from glucose to fatty acids Brunmair, B.
 2006
 49 11 p. 2713-2722
 article
2 A prospective study of dietary patterns, meat intake and the risk of gestational diabetes mellitus Zhang, C.
 2006
 49 11 p. 2604-2613
 article
3 Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes Tan, K. C. B.
 2006
 49 11 p. 2756-2762
 article
4 Beta cell death in hyperglycaemic Psammomys obesus is not cytokine-mediated Jörns, A.
 2006
 49 11 p. 2704-2712
 article
5 Circulating concentrations of high-molecular-weight adiponectin are increased following Roux-en-Y gastric bypass surgery Swarbrick, M. M.
 2006
 49 11 p. 2552-2558
 article
6 Coffee consumption and risk of total and cardiovascular mortality among patients with type 2 diabetes Bidel, S.
 2006
 49 11 p. 2618-2626
 article
7 Comment on: Evans JMM, Ogston SA, Emslie-Smith A, Morris AD (2006) Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin. Diabetologia 49:930–936 Tayek, J. A.
 2006
 49 11 p. 2807-2808
 article
8 Comment on: Evans JM, Ogston SA, Emslie-Smith A, Morris A (2006) Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin. Diabetologia 49:930–936 Johnson, J. A.
 2006
 49 11 p. 2805-2806
 article
9 Comment on: Haider DG, Schaller G, Kapiotis S, Maier C, Luger A, Wolzt M (2006) The release of the adipocytokine visfatin is regulated by glucose and insulin. Diabetologia 49:1909–1914 Pfützner, A.
 2006
 49 11 p. 2795
 article
10 Comment on: Kalra B, Kalra S, Chatley G, Singh H (2006) Rat bite as a cause of diabetic foot ulcer—a series of eight cases. Diabetologia 49:1452–1453 Abbas, Z. G.
 2006
 49 11 p. 2811-2812
 article
11 Comment on: Knol MJ, Twisk JWR, Beekman ATF, Heine RJ, Snoek FJ, Pouwer F. (2006) Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis. Diabetologia; 49: 837–845 Jonge, P. de
 2006
 49 11 p. 2797-2798
 article
12 Comment on: Meier JJ, Lin JC, Butler AE, Galasso R, Martinez DS, Butler PC (2006) Direct evidence of attempted beta cell regeneration in an 89-year-old patient with recent-onset type 1 diabetes. Diabetologia 49:1838–1844 Zhao, H.-L.
 2006
 49 11 p. 2801-2802
 article
13 Comment on: Nyirenda MJ, Dean S, Lyons V, Chapman KE, Seckl JR (2006) Prenatal programming of hepatocyte nuclear factor 4a in the rat: a key mechanism in the ‘foetal origins of hyperglycaemia’? Diabetologia 49: 1412–1420, and on: McCurdy CE, Friedman JE (2006) Early foetal programming of hepatic gluconeogenesis: glucocorticoids strike back. Diabetologia 49:1138–1141 Burns, S. P.
 2006
 49 11 p. 2809-2810
 article
14 Comment on: White PJ, Marette A (2006) Is omega-3 key to unlocking inflammation in obesity? Diabetologia 49:1999–2001 Cereda, E.
 2006
 49 11 p. 2813-2814
 article
15 Degeneration of the Golgi and neuronal loss in dorsal root ganglia in diabetic BioBreeding/Worcester rats Kamiya, H.
 2006
 49 11 p. 2763-2774
 article
16 Do known risk factors explain the higher coronary heart disease mortality in South Asian compared with European men? Prospective follow-up of the Southall and Brent studies, UK Forouhi, N. G.
 2006
 49 11 p. 2580-2588
 article
17 Dynorphin A, kappa opioid receptors and the antinociceptive efficacy of asimadoline in streptozotocin-induced diabetic rats Jolivalt, C. G.
 2006
 49 11 p. 2775-2785
 article
18 Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitus Raz, I.
 2006
 49 11 p. 2564-2571
 article
19 Embryonic stem cell-based diabetes therapy—a long road to travel Serup, P.
 2006
 49 11 p. 2537-2540
 article
20 From the coalface: does glargine insulin improve hypoglycaemic episodes, glycaemic control or affect body mass in type 1 diabetic subjects who are attending a ‘routine’ diabetes clinic? Distiller, L. A.
 2006
 49 11 p. 2793-2794
 article
21 Generation of pancreatic insulin-producing cells from embryonic stem cells — ‘Proof of principle’, but questions still unanswered Rolletschek, A.
 2006
 49 11 p. 2541-2545
 article
22 Genetic control of plasma lipid levels in a cross derived from normoglycaemic Brown Norway and spontaneously diabetic Goto–Kakizaki rats Argoud, K.
 2006
 49 11 p. 2679-2688
 article
23 Genotype of galectin 2 (LGALS2) is associated with insulin-glucose profile in the British Women’s Heart and Health Study Christensen, M. B.
 2006
 49 11 p. 2815
 article
24 Global myocardial perfusion and diastolic function are impaired to a similar extent in patients with type 2 diabetes mellitus and in patients with coronary artery disease—evaluation by contrast echocardiography and pulsed tissue Doppler Dounis, V.
 2006
 49 11 p. 2729-2740
 article
25 How to make beta cells from embryonic cells Scharfmann, R.
 2006
 49 11 p. 2535-2536
 article
26 Improved motor development and good long-term glycaemic control with sulfonylurea treatment in a patient with the syndrome of intermediate developmental delay, early-onset generalised epilepsy and neonatal diabetes associated with the V59M mutation in the KCNJ11 gene Slingerland, A. S.
 2006
 49 11 p. 2559-2563
 article
27 Increased insulin secretory capacity but decreased insulin sensitivity after correction of iron overload by phlebotomy in hereditary haemochromatosis Abraham, D.
 2006
 49 11 p. 2546-2551
 article
28 Increased islet beta cell replication adjacent to intrapancreatic gastrinomas in humans Meier, J. J.
 2006
 49 11 p. 2689-2696
 article
29 Induction of the chemokine interferon-γ-inducible protein-10 in human pancreatic islets during enterovirus infection Berg, A.-K.
 2006
 49 11 p. 2697-2703
 article
30 Low cerebrospinal fluid insulin levels in obese humans Kern, W.
 2006
 49 11 p. 2790-2792
 article
31 Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy Nathan, D. M.
 2006
 49 11 p. 2816-2818
 article
32 Offspring birthweight is not associated with paternal insulin resistance Knight, B.
 2006
 49 11 p. 2675-2678
 article
33 PARL Leu262Val is not associated with fasting insulin levels in UK populations Fawcett, K. A.
 2006
 49 11 p. 2649-2652
 article
34 Paternal insulin resistance and its association with umbilical cord insulin concentrations Shields, B. M.
 2006
 49 11 p. 2668-2674
 article
35 Phosphatidylinositol 3-kinase p85α regulatory subunit gene PIK3R1 haplotype is associated with body fat and serum leptin in a female twin population Jamshidi, Y.
 2006
 49 11 p. 2659-2667
 article
36 Polymorphisms in the gene encoding sterol regulatory element-binding factor-1c are associated with type 2 diabetes Harding, A.-H.
 2006
 49 11 p. 2642-2648
 article
37 Predicting impaired glucose metabolism in women with polycystic ovary syndrome by decision tree modelling Möhlig, M.
 2006
 49 11 p. 2572-2579
 article
38 Predictors, consequences and costs of diabetes-related lower extremity amputation complicating type 2 diabetes: The Fremantle Diabetes Study Davis, W. A.
 2006
 49 11 p. 2634-2641
 article
39 Prevalent and incident depression in community-dwelling elderly persons with diabetes mellitus: results from the ZARADEMP project Jonge, P. de
 2006
 49 11 p. 2627-2633
 article
40 Reply to comment on: Knol MJ, Twisk JWR, Beekman ATF, Heine RJ, Snoek FJ, Pouwer F (2006) Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis. Diabetologia 49:837–845 Pouwer, F.
 2006
 49 11 p. 2799-2800
 article
41 Response to comment on: Haider DG, Schaller G, Kapiotis S, Maier C, Luger A, Wolzt M (2006) The release of the adipocytokine visfatin is regulated by glucose and insulin. Diabetologia 49:1909–1914 Haider, D. G.
 2006
 49 11 p. 2796
 article
42 Response to comment on: Meier JJ, Lin JC, Butler AE, Galasso R, Martinez DS, Butler PC (2006) Direct evidence of attempted beta cell regeneration in an 89-year-old patient with recent-onset type 1 diabetes. Diabetologia 49:1838–1844 Meier, J. J.
 2006
 49 11 p. 2803-2804
 article
43 Sympathetic nerve hyperactivity in non-diabetic offspring of patients with type 2 diabetes mellitus Huggett, R. J.
 2006
 49 11 p. 2741-2744
 article
44 The associations of birthweight, gestational age and childhood BMI with type 2 diabetes: findings from the Aberdeen Children of the 1950s cohort Lawlor, D. A.
 2006
 49 11 p. 2614-2617
 article
45 The chemokine (C-X-C motif) receptor 4 inhibitor AMD3100 accelerates blood flow restoration in diabetic mice Jiao, C.
 2006
 49 11 p. 2786-2789
 article
46 The impact of family history of diabetes and lifestyle factors on abnormal glucose regulation in middle-aged Swedish men and women Hilding, A.
 2006
 49 11 p. 2589-2598
 article
47 The −374 T/A polymorphism in the gene encoding RAGE is associated with diabetic nephropathy and retinopathy in type 1 diabetic patients Lindholm, E.
 2006
 49 11 p. 2745-2755
 article
48 Three-year increase of gamma-glutamyltransferase level and development of type 2 diabetes in middle-aged men and women: the D.E.S.I.R. cohort André, P.
 2006
 49 11 p. 2599-2603
 article
49 Upregulation of adiponectin receptor 1 and 2 mRNA and protein in adipose tissue and adipocytes in insulin-resistant women with polycystic ovary syndrome Tan, B. K.
 2006
 49 11 p. 2723-2728
 article
50 Variants in the 5′ region of the neuropeptide Y receptor Y2 gene (NPY2R) are associated with obesity in 5,971 white subjects Torekov, S. S.
 2006
 49 11 p. 2653-2658
 article
                             50 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands